Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

Q: What does CUSIP 761330109 represent in this 13F holders report?

CUSIP 761330109 is the security identifier for RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q1 2015?

70 institutional investors reported RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q1 2015. Use the holders table for investor-level position and value details.

CUSIP: 761330109

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 104,661,494
Total 13F shares: 20,573,529
Share change: +775,267
Total reported value: $426,461,171
Put/Call ratio: 164%
Price per share: $20.73
Number of holders: 70
Value change: +$18,511,994
Number of buys: 42
Number of sells: 25

Quarterly Holders Quick Answers

What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2015
Previous quarter: Q4 2014

Recent filing periods for CUSIP 761330109:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Essex Woodlands Management, Inc.	13F	Company	4.4%	4,592,047	$77,789,000	—	31 Dec 2014	13F
NQ HCIF GP, Ltd.	13F	Company	3%	3,096,650	$52,457,000	—	31 Dec 2014	13F
FRANKLIN RESOURCES INC	13F	Company	2.6%	2,754,139	$46,654,000	—	31 Dec 2014	13F
Polar Capital LLP	13F	Company	1.1%	1,107,272	$18,756,000	—	31 Dec 2014	13F
Bank of New York Mellon Corp	13F	Company	0.98%	1,023,422	$17,337,000	—	31 Dec 2014	13F
Visium Asset Management, LP	13F	Company	0.96%	1,000,000	$16,940,000	—	31 Dec 2014	13F
ArrowMark Colorado Holdings LLC	13F	Company	0.75%	787,923	$13,347,000	—	31 Dec 2014	13F
JPMORGAN CHASE & CO	13F	Company	0.69%	722,276	$12,236,000	—	31 Dec 2014	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.55%	575,906	$9,756,000	—	31 Dec 2014	13F
BlackRock Fund Advisors	13F	Company	0.49%	515,592	$8,734,000	—	31 Dec 2014	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.38%	402,755	$6,823,000	—	31 Dec 2014	13F
VANGUARD GROUP INC	13F	Company	0.37%	383,898	$6,503,000	—	31 Dec 2014	13F
WADDELL & REED FINANCIAL INC	13F	Company	0.33%	349,050	$5,913,000	—	31 Dec 2014	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.24%	252,494	$4,277,000	—	31 Dec 2014	13F
Lombard Odier Asset Management (USA) Corp	13F	Company	0.24%	250,605	$4,245,000	—	31 Dec 2014	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.15%	160,212	$2,714,000	—	31 Dec 2014	13F
Rhenman & Partners Asset Management AB	13F	Company	0.12%	126,574	$2,144,000	—	31 Dec 2014	13F
JENNISON ASSOCIATES LLC	13F	Company	0.1%	109,125	$1,849,000	—	31 Dec 2014	13F
STATE STREET CORP	13F	Company	0.1%	103,742	$1,756,000	—	31 Dec 2014	13F
Jefferies Group LLC	13F	Company	0.1%	100,000	$1,694,000	—	31 Dec 2014	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.09%	94,622	$1,603,000	—	31 Dec 2014	13F
NORTHERN TRUST CORP	13F	Company	0.09%	92,450	$1,566,000	—	31 Dec 2014	13F
LEVIN CAPITAL STRATEGIES, L.P.	13F	Company	0.08%	87,984	$1,490,000	—	31 Dec 2014	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.08%	86,552	$1,466,000	—	31 Dec 2014	13F
Zweig-DiMenna Associates LLC	13F	Company	0.08%	83,000	$1,406,000	—	31 Dec 2014	13F
SABBY MANAGEMENT, LLC	13F	Company	0.07%	76,400	$1,294,000	—	31 Dec 2014	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.07%	72,438	$1,227,000	—	31 Dec 2014	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.06%	65,200	$1,104,000	—	31 Dec 2014	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.06%	64,904	$1,099,000	—	31 Dec 2014	13F
WALL STREET ASSOCIATES	13F	Company	0.05%	57,330	$971,000	—	31 Dec 2014	13F
CITADEL ADVISORS LLC	13F	Company	0.05%	49,974	$846,000	—	31 Dec 2014	13F
Standard Investments LLC	13F	Company	0.05%	47,846	$811,000	—	31 Dec 2014	13F
BAMCO INC /NY/	13F	Company	0.04%	43,000	$728,000	—	31 Dec 2014	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.04%	38,018	$644,000	—	31 Dec 2014	13F
CREDIT SUISSE AG/	13F	Company	0.04%	37,388	$633,000	—	31 Dec 2014	13F
Robert W. Baird & Co. Inc	13F	Company	0.03%	32,832	$556,000	—	31 Dec 2014	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.03%	29,393	$498,000	—	31 Dec 2014	13F
BlackRock Investment Management, LLC	13F	Company	0.03%	26,536	$450,000	—	31 Dec 2014	13F
State of New Jersey Common Pension Fund D	13F	Company	0.02%	26,000	$440,000	—	31 Dec 2014	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	25,165	$427,000	—	31 Dec 2014	13F
C Partners Holding GmbH	13F	Company	0.02%	24,000	$407,000	—	31 Dec 2014	13F
NOTTINGHAM ADVISORS, INC.	13F	Company	0.02%	23,018	$390,000	—	31 Dec 2014	13F
Nationwide Fund Advisors	13F	Company	0.02%	18,559	$314,000	—	31 Dec 2014	13F
Trexquant Investment LP	13F	Company	0.02%	17,800	$301,000	—	31 Dec 2014	13F
ProShare Advisors LLC	13F	Company	0.02%	17,544	$297,000	—	31 Dec 2014	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	15,940	$270,000	—	31 Dec 2014	13F
Swiss National Bank	13F	Company	0.01%	12,950	$219,000	—	31 Dec 2014	13F
TFS CAPITAL LLC	13F	Company	0.01%	11,213	$190,000	—	31 Dec 2014	13F
TEACHERS ADVISORS, LLC	13F	Company	0.01%	10,524	$178,000	—	31 Dec 2014	13F
CITIGROUP INC	13F	Company	0.01%	7,840	$133,000	—	31 Dec 2014	13F

Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q1 2015

As of 31 Mar 2015, Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,573,529 shares. The largest 10 holders included Essex Woodlands Health Ventures, Inc., FRANKLIN RESOURCES INC, NQ HCIF GP, Ltd., JPMORGAN CHASE & CO, Bank of New York Mellon Corp, Visium Asset Management, LP, Polar Capital LLP, Arrowpoint Asset Management, LLC, BlackRock Fund Advisors, and VANGUARD GROUP INC. This page lists 70 institutional shareholders reporting positions in this security for the Q1 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2015 vs Q4 2014 Across Filers

Q4 2014 holders

Q1 2015 holders

Holder diff

Investor	Q4 2014 Shares	Q1 2015 Shares	Share Diff	Share Chg %	Q4 2014 Value $	Q1 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.